On April 27, 2026, the National Medical Products Administration (NMPA) announced that Jiangsu Huayang Pharmaceutical’s extended-release tablets became the first generic upadacitinib approved in China after passing generic consistency evaluation. This milestone—generic upadacitinib approved in china—marks the first approved generic…
Over the past decade, autoimmune diseases have remained one of the most stable and high-growth areas in global drug innovation. From TNF-α inhibitors to IL-17/IL-23 biologics and the rise of JAK inhibitors, the field has undergone multiple waves of therapeutic…
As global drug patents continue to expire, the China Generic Drug Market Trends 2026 indicate that the industry is entering a new cycle of competition and opportunity. Around 2026, the Chinese pharmaceutical industry is approaching an important milestone. Several globally…
According to the National Medical Products Administration (NMPA), three innovative drugs were approved for marketing in China in February 2026. These newly added entries to the NMPA approved drugs list cover moderate-to-severe plaque psoriasis, myelofibrosis, and KRAS G12C–mutant advanced non-small…
What is Taltz ixekizumab used for? This is a common question among patients and healthcare professionals seeking clearer information about modern biologic therapies for immune-mediated inflammatory diseases. As treatment strategies continue to evolve toward targeted and precision-based approaches, understanding how…
As global demographic shifts, evolving disease landscapes, and rising expectations for treatment experience continue to reshape healthcare, the pharmaceutical industry is facing unprecedented opportunities and challenges. As a critical bridge between pharmaceutical innovation and clinical practice, Hong Kong DengYue Medicine…
Generic Name/Brand Name: Anti-Human Interleukin/Enboke Indications: Inflammatory skin diseases Dosage Form: Topical cream Specification: 10 g × 1 tube
Generic Name/Brand Name: Infliximab/Remicade Indications: Rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn’s disease, Ulcerative colitis, plaque psoriasis Dosage Form: Lyophilized powder for injection Specification: 100 mg × 1 vial
Source: Dengyuemed | September 5, 2025 | Category: Pharmaceuticals As a Hong Kong Drug Wholesale Distributor, we maintain an open attitude of learning, keeping a close eye on the progress and achievements of new TCM approvals in China. Recently, China’s…
Generic Name/Brand Name: Adalimumab/AnJiaRun Indications: Uveitis, Plaque Psoriasis, Crohn’s Disease, Psoriatic Arthritis… Dosage Form: Solution for Injection Specification: 40mg(0.8ml) x 1 vial
